Patent · US Active

Delayed release pancreatin compositions

US9198871B2 · kind B2 · utility

1Cited by
74References
32Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 15, 2006
Grant dateDec 1, 2015
Priority date
Expiry dateFeb 7, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y304/21004
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.